Lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, has shown 100% efficacy in preventing HIV in women at a high risk for infection, according to an interim analysis of the phase 3 PURPOSE ...

Three women likely contracted HIV after receiving so-called "vampire facials" at an unlicensed spa in New Mexico, according to a new report published by the Centers for Disease Control and Prevention ...

Using participant skin cells reprogrammed into neurons, Weill Cornell Medicine researchers have identified genetic signatures associated with HIV infection that may contribute to the cognitive ...

Medicines that treat HIV are called antiretroviral therapy (ART). Genvoya is a combination tablet that contains the following four medicines that work together to treat HIV. Cobicistat is a “booster.” ...

The patient is a 32-year-old man with HIV diagnosed in 1995 after presenting with cryptococcal meningitis. The patient recovered from the meningitis and was prescribed secondary prophylaxis with ...

The Centers for Disease Control and Prevention said new HIV infections declined 12% from 2017 to 2021. However, there are deep racial disparities that threaten to stymie U.S. efforts to reduce new ...

While older patients with HIV had a higher risk for cutaneous malignancies than younger adults with HIV, both groups had significantly higher risks for oncovirus infections when compared with control ...